- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | SRV YHTIOT OYJ: SRV will implement right-of-occupancy housing units for Vaso in Kuloistenniitty, Raisio - the units will have an energy class A rating | 4 | Cision News | ||
| VASO Aktie jetzt für 0€ handeln | |||||
| 16.12. | Vaso Corporation CEO Reflects on a Year of Growth and Innovation in End-of-Year Letter Setting the Tone for a Promising 2025 | 1 | GlobeNewswire (Europe) | Vaso Corporation137 Commercial StreetPlainview, New York 11803Tel: (516) 997-4600 Fax: (516) 997-2299 NEWS RELEASE PLAINVIEW, N.Y., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX:... ► Artikel lesen | |
| 22.11. | Vaso Corp CEO Ma Jun erwirbt Stammaktien im Wert von 26.000 US-Dollar | 1 | Investing.com Deutsch | ||
| 14.11. | Vasomedical reports Q3 results | 1 | Seeking Alpha | ||
| 14.11. | Vaso Corporation Announces Financial Results for Third Quarter 2024 | 66 | GlobeNewswire (Europe) | PLAINVIEW, N.Y., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO), a leading medtech company with a diversified business portfolio in network and healthcare IT services, professional... ► Artikel lesen | |
| 19.09. | Vaso announces termination of business combination with Achari Ventures Holdings Corp. I | 1 | Seeking Alpha | ||
| 19.09. | Vaso Corporation Announces Termination of Business Combination Agreement with Achari Ventures Holdings Corp. I | 119 | GlobeNewswire (Europe) | PLAINVIEW, N.Y., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO) today announced that it has provided notice to Achari Ventures Holdings Corp. I ("Achari") to terminate... ► Artikel lesen | |
| 19.09. | VASO Corp - 8-K, Current Report | - | SEC Filings | ||
| 10.09. | VASO Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 26.08. | Vaso Corporation Announces Date Change for Its Stockholders Meeting | 1 | GlobeNewswire (USA) | ||
| 23.08. | Vaso Corp announces pro forma financials amid business combination | 1 | Investing.com | ||
| 23.08. | VASO Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 16.08. | VASO Q2 Earnings Flat Y/Y, Revenues Down, Gross Margin Contracts | 1 | Zacks | ||
| 15.08. | Vasomedical reports Q2 results | 1 | Seeking Alpha | ||
| 14.08. | VASO Corp - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 14.08. | Vaso Corporation Announces Financial Results for Second Quarter 2024 | 102 | GlobeNewswire (Europe) | High deferred revenue and backlog setting stage for 2024 revenue and income growth PLAINVIEW, N.Y., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO) today reported its operating... ► Artikel lesen | |
| 07.08. | Vaso Corporation Announces the Effectiveness of the Achari Ventures Holdings Corp. I Registration Statement on Form S-4 | 1 | GlobeNewswire (USA) | ||
| 25.07. | Zacks Initiates Coverage of Vaso With Neutral Recommendation | 1 | Zacks | ||
| 15.05. | Vaso Corporation Announces Financial Results for First Quarter 2024 | 129 | GlobeNewswire (Europe) | PLAINVIEW, N.Y., May 15, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO) today reported its operating results for the three months ended March 31, 2024. "Total revenue for the first... ► Artikel lesen | |
| 01.04. | Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year of 2023 | 102 | GlobeNewswire (Europe) | PLAINVIEW, N.Y., April 01, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO) today announced its operating results for the three months and year ended December 31, 2023. "The Company... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 18,936 | +0,35 % | Bayer AG Aktie: Weitere Verluste erwartet | Die Bayer-Aktie verzeichnete am Handelstag einen deutlichen Rückgang und fiel im XETRA-Handel um 0,6 Prozent auf 19,64 Euro. Der Anteilsschein, der Anfang Januar noch bei 36,09 Euro notierte, entfernt... ► Artikel lesen | |
| ASTRAZENECA | 124,55 | +0,04 % | DEUTSCHE BANK RESEARCH stuft ASTRAZENECA auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Astrazeneca mit einem Kursziel von 10500 Pence auf "Hold" belassen. Dies schrieb Analyst Emmanuel Papadakis in seinem am... ► Artikel lesen | |
| EYEPOINT PHARMACEUTICALS | 7,004 | +2,67 % | EyePoint Pharmaceuticals, Inc.: EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | WATERTOWN, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients... ► Artikel lesen | |
| IONIS PHARMACEUTICALS | 33,930 | -0,73 % | IONIS PHARMACEUTICALS INC - 8-K, Current Report | ||
| CSPC PHARMA | 0,600 | 0,00 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - SYS6005 (ANTIBODY-DRUG CONJUGATE) OBTAINS CLINICAL TRIAL APPROVAL | ||
| ACADIA PHARMACEUTICALS | 16,125 | -0,37 % | Acadia Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operating Overview | SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced its financial results for the third quarter ended September 30, 2024.
"The success of Acadia's two growing... ► Artikel lesen | |
| SELLAS LIFE SCIENCES | 0,875 | +0,81 % | SELLAS Life Sciences Group, Inc.: SELLAS Life Sciences Triggers Interim Analysis in Phase 3 REGAL Trial of GPS in Acute Myeloid Leukemia | - Study Reaches Pre-Specified Threshold of 60 Events (Deaths) Initiating the Interim Analysis - - REGAL Independent Data Monitoring Committee to Perform Interim Analysis in January 2025 - - Company... ► Artikel lesen | |
| MADRIGAL PHARMACEUTICALS | 288,80 | -2,40 % | Arrowhead Pharma und Madrigal gehen steil: Zwischen Adipositas- und Übernahmefantasie | Die Biotechnologie-Branche bietet viele spannende Storys. Einen aussichtsreichen Aktienkorb mit 14 verschiedenen Titeln bildet der Biotech Supertrends Index ab. Zuletzt sorgten im Index vor allem die... ► Artikel lesen | |
| CATALYST PHARMACEUTICALS | 20,330 | -0,29 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Received Approval to Commercialize FIRDAPSE in Japan | CORAL GABLES, Fla., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing... ► Artikel lesen | |
| OPUS GENETICS | 1,028 | +7,76 % | Opus Genetics, Inc.: Opus Genetics Receives FDA Agreement Under Special Protocol Assessment for Phase 3 Trial of APX3330 in Diabetic Retinopathy | Agreement Reached on Primary Endpoint and Phase 3 Trial Design Oral APX3330 is a Late-Stage Clinical Asset Available for Partnering FARMINGTON HILLS, Mich., Dec. 19, 2024 (GLOBE NEWSWIRE) --... ► Artikel lesen | |
| ENZON PHARMACEUTICALS | 0,092 | -22,46 % | ENZON PHARMACEUTICALS, INC. - 10-Q, Quarterly Report | ||
| CHUGAI PHARMACEUTICAL | 40,510 | -0,78 % | Warum die Chugai-Aktie am Dienstag einen Sprung machte | ||
| VIRACTA THERAPEUTICS | 0,226 | +4,63 % | Viracta Therapeutics, Inc.: Viracta Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update | - Reprioritized resources to reduce costs and enhance focus on Nana-val's development program in relapsed or refractory EBV-positive peripheral T-cell lymphoma (PTCL) - - On track to report... ► Artikel lesen | |
| ELITE PHARMACEUTICALS | - | - | Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals Announces Commercial Launch of Acetaminophen and Hydrocodone Tablets | Northvale, New Jersey--(Newsfile Corp. - December 2, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products... ► Artikel lesen | |
| SAVARA | 3,100 | -0,64 % | Savara (NASDAQ:SVRA) Now Covered by Analysts at Wells Fargo & Company |
VASO CORPORATION gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VASO CORPORATION finden Sie auf Wallstreet Online.
